Annual summary of publications

Publications (original articles or review articles) published in 2012 from OUS - Section of Preventive Medicine

42 publications found

Aksnes TA, Skårn SN, Kjeldsen SE (2012)
Treatment of hypertension in diabetes: what is the best therapeutic option?
Expert Rev Cardiovasc Ther, 10 (6), 727-34
DOI 10.1586/erc.12.59, PubMed 22894629

Boekholdt SM, Arsenault BJ, Mora S, Pedersen TR, LaRosa JC, Nestel PJ, Simes RJ, Durrington P, Hitman GA, Welch KM, DeMicco DA, Zwinderman AH, Clearfield MB, Downs JR, Tonkin AM, Colhoun HM, Gotto AM, Ridker PM, Kastelein JJ (2012)
Association of LDL cholesterol, non-HDL cholesterol, and apolipoprotein B levels with risk of cardiovascular events among patients treated with statins: a meta-analysis
JAMA, 307 (12), 1302-9
DOI 10.1001/jama.2012.366, PubMed 22453571

Cameron J, Bogsrud MP, Tveten K, Strøm TB, Holven K, Berge KE, Leren TP (2012)
Serum levels of proprotein convertase subtilisin/kexin type 9 in subjects with familial hypercholesterolemia indicate that proprotein convertase subtilisin/kexin type 9 is cleared from plasma by low-density lipoprotein receptor-independent pathways
Transl Res, 160 (2), 125-30
DOI 10.1016/j.trsl.2012.01.010, PubMed 22683370

Farnier M, Marcereuil D, De Niet S, Ducobu J, Steinmetz A, Retterstøl K, Bryniarski L, Császár A, Vanderbist F (2012)
Safety of a fixed-dose combination of fenofibrate/pravastatin 160 mg/40 mg in patients with mixed hyperlipidaemia: a pooled analysis from a database of clinical trials
Clin Drug Investig, 32 (4), 281-91
DOI 10.2165/11630820-000000000-00000, PubMed 22350498

Farnier M, Retterstøl K, Steinmetz A, Császár A (2012)
Comparative efficacy and safety of fenofibrate/pravastatin plus ezetimibe triple therapy and simvastatin/ezetimibe dual therapy in type 2 diabetic patients with mixed hyperlipidaemia and cardiovascular disease
Diab Vasc Dis Res, 9 (3), 205-15
DOI 10.1177/1479164111430715, PubMed 22228773

Fretheim A, Odgaard-Jensen J, Brørs O, Madsen S, Njølstad I, Norheim OF, Svilaas A, Kristiansen IS, Thürmer H, Flottorp S (2012)
Comparative effectiveness of antihypertensive medication for primary prevention of cardiovascular disease: systematic review and multiple treatments meta-analysis
BMC Med, 10, 33
DOI 10.1186/1741-7015-10-33, PubMed 22480336

Græsdal A, Bogsrud MP, Holven KB, Nenseter MS, Narverud I, Langslet G, Brekke M, Retterstøl K, Arnesen KE, Ose L (2012)
Apheresis in homozygous familial hypercholesterolemia: the results of a follow-up of all Norwegian patients with homozygous familial hypercholesterolemia
J Clin Lipidol, 6 (4), 331-9
DOI 10.1016/j.jacl.2012.03.004, PubMed 22836070

Grundvold I, Skretteberg PT, Liestøl K, Erikssen G, Kjeldsen SE, Arnesen H, Erikssen J, Bodegard J (2012)
Upper normal blood pressures predict incident atrial fibrillation in healthy middle-aged men: a 35-year follow-up study
Hypertension, 59 (2), 198-204
DOI 10.1161/HYPERTENSIONAHA.111.179713, PubMed 22252392

Grundvold I, Skretteberg PT, Liestøl K, Gjesdal K, Erikssen G, Kjeldsen SE, Arnesen H, Erikssen J, Bodegard J (2012)
Importance of physical fitness on predictive effect of body mass index and weight gain on incident atrial fibrillation in healthy middle-age men
Am J Cardiol, 110 (3), 425-32
DOI 10.1016/j.amjcard.2012.03.043, PubMed 22579085

Hamrefors V, Sjögren M, Almgren P, Wahlstrand B, Kjeldsen S, Hedner T, Melander O (2012)
Pharmacogenetic implications for eight common blood pressure-associated single-nucleotide polymorphisms
J Hypertens, 30 (6), 1151-60
DOI 10.1097/HJH.0b013e3283536338, PubMed 22525200

Hassellund SS, Flaa A, Kjeldsen SE, Seljeflot I, Karlsen A, Erlund I, Rostrup M (2012)
Effects of anthocyanins on cardiovascular risk factors and inflammation in pre-hypertensive men: a double-blind randomized placebo-controlled crossover study
J Hum Hypertens, 27 (2), 100-6
DOI 10.1038/jhh.2012.4, PubMed 22336903

Heggen E, Klemsdal TO, Haugen F, Holme I, Tonstad S (2012)
Effect of a low-fat versus a low-gycemic-load diet on inflammatory biomarker and adipokine concentrations
Metab Syndr Relat Disord, 10 (6), 437-42
DOI 10.1089/met.2012.0012, PubMed 22889406

Hodnesdal C, Prestgaard E, Erikssen G, Gjesdal K, Kjeldsen SE, Liestol K, Skretteberg PT, Erikssen J, Bodegard J (2012)
Rapidly upsloping ST-segment on exercise ECG: a marker of reduced coronary heart disease mortality risk
Eur J Prev Cardiol, 20 (4), 541-8
DOI 10.1177/2047487312444370, PubMed 22492865

Holme I, Fellström BC, Jardine AG, Hartmann A, Holdaas H (2012)
Model comparisons of competing risk and recurrent events for graft failure in renal transplant recipients
Clin J Am Soc Nephrol, 8 (2), 241-7
DOI 10.2215/CJN.03760412, PubMed 23160259

Karlsen A, Svendsen M, Seljeflot I, Laake P, Duttaroy AK, Drevon CA, Arnesen H, Tonstad S, Blomhoff R (2012)
Kiwifruit decreases blood pressure and whole-blood platelet aggregation in male smokers
J Hum Hypertens, 27 (2), 126-30
DOI 10.1038/jhh.2011.116, PubMed 22258209

Kjeldsen SE, Messerli FH, Chiang CE, Meredith PA, Liu L (2012)
Are fixed-dose combination antihypertensives suitable as first-line therapy?
Curr Med Res Opin, 28 (10), 1685-97
DOI 10.1185/03007995.2012.729505, PubMed 22978777

Larstorp AC, Ariansen I, Gjesdal K, Olsen MH, Ibsen H, Devereux RB, Okin PM, Dahlöf B, Kjeldsen SE, Wachtell K (2012)
Association of pulse pressure with new-onset atrial fibrillation in patients with hypertension and left ventricular hypertrophy: the Losartan Intervention For Endpoint (LIFE) reduction in hypertension study
Hypertension, 60 (2), 347-53
DOI 10.1161/HYPERTENSIONAHA.112.195032, PubMed 22753219

Larstorp AC, Okin PM, Devereux RB, Olsen MH, Ibsen H, Dahlöf B, Kjeldsen SE, Wachtell K (2012)
Regression of ECG-LVH is associated with lower risk of new-onset heart failure and mortality in patients with isolated systolic hypertension; The LIFE study
Am J Hypertens, 25 (10), 1101-9
DOI 10.1038/ajh.2012.86, PubMed 22717544

Manolis AJ, Rosei EA, Coca A, Cifkova R, Erdine SE, Kjeldsen S, Lip GY, Narkiewicz K, Parati G, Redon J, Schmieder R, Tsioufis C, Mancia G (2012)
Hypertension and atrial fibrillation: diagnostic approach, prevention and treatment. Position paper of the Working Group 'Hypertension Arrhythmias and Thrombosis' of the European Society of Hypertension
J Hypertens, 30 (2), 239-52
DOI 10.1097/HJH.0b013e32834f03bf, PubMed 22186358

Narverud I, Halvorsen B, Nenseter MS, Retterstøl K, Yndestad A, Dahl TB, Ulven SM, Olstad OK, Ose L, Holven KB, Aukrust P (2012)
Oxidized LDL level is related to gene expression of tumour necrosis factor super family members in children and young adults with familial hypercholesterolaemia
J Intern Med, 273 (1), 69-78
DOI 10.1111/j.1365-2796.2012.02584.x, PubMed 22891927

Narverud I, Iversen PO, Aukrust P, Halvorsen B, Ueland T, Johansen SG, Nenseter MS, Sandset PM, Ulven SM, Ose L, Retterstøl K, Holven KB (2012)
Maternal familial hypercholesterolaemia (FH) confers altered haemostatic profile in offspring with and without FH
Thromb Res, 131 (2), 178-82
DOI 10.1016/j.thromres.2012.11.008, PubMed 23199546

Nenseter MS, Narverud I, Græsdal A, Bogsrud MP, Aukrust P, Retterstøl K, Ose L, Halvorsen B, Holven KB (2012)
Cholesterol efflux mediators in homozygous familial hypercholesterolemia patients on low-density lipoprotein apheresis
J Clin Lipidol, 7 (2), 109-16
DOI 10.1016/j.jacl.2012.08.001, PubMed 23415429

Nenseter MS, Narverud I, Græsdal A, Bogsrud MP, Halvorsen B, Ose L, Aukrust P, Holven KB (2012)
Elevated serum MMP-9/TIMP-1 ratio in patients with homozygous familial hypercholesterolemia: effects of LDL-apheresis
Cytokine, 61 (1), 194-8
DOI 10.1016/j.cyto.2012.09.016, PubMed 23131422

Okin PM, Hille DA, Kjeldsen SE, Dahlöf B, Devereux RB (2012)
Impact of lower achieved blood pressure on outcomes in hypertensive patients
J Hypertens, 30 (4), 802-10; discussion 810
DOI 10.1097/HJH.0b013e3283516499, PubMed 22343536

Okin PM, Kjeldsen SE, Lindholm LH, Dahlöf B, Devereux RB (2012)
The relationship of electrocardiographic left ventricular hypertrophy to decreased serum potassium
Blood Press, 21 (3), 146-52
DOI 10.3109/08037051.2011.649537, PubMed 22243363

Perlini S, Naditch-Brule L, Farsang C, Zidek W, Kjeldsen SE (2012)
Pulse pressure and heart rate in patients with metabolic syndrome across Europe: insights from the GOOD survey
J Hum Hypertens, 27 (7), 412-6
DOI 10.1038/jhh.2012.61, PubMed 23235366

Preiss D, Tikkanen MJ, Welsh P, Ford I, Lovato LC, Elam MB, LaRosa JC, DeMicco DA, Colhoun HM, Goldenberg I, Murphy MJ, MacDonald TM, Pedersen TR, Keech AC, Ridker PM, Kjekshus J, Sattar N, McMurray JJ (2012)
Lipid-modifying therapies and risk of pancreatitis: a meta-analysis
JAMA, 308 (8), 804-11
DOI 10.1001/jama.2012.8439, PubMed 22910758

Rollefstad S, Kvien TK, Holme I, Eirheim AS, Pedersen TR, Semb AG (2012)
Treatment to lipid targets in patients with inflammatory joint diseases in a preventive cardio-rheuma clinic
Ann Rheum Dis, 72 (12), 1968-74
DOI 10.1136/annrheumdis-2012-202789, PubMed 23264359

Ruwald AC, Westergaard B, Sehestedt T, Kjeldsen SE, Lindholm LH, Wachtell K, Devereux RB, Ibsen H, Nieminen MS, Dahlöf B, Olsen MH (2012)
Losartan versus atenolol-based antihypertensive treatment reduces cardiovascular events especially well in elderly patients: the Losartan Intervention For Endpoint reduction in hypertension (LIFE) study
J Hypertens, 30 (6), 1252-9
DOI 10.1097/HJH.0b013e328352f7f6, PubMed 22499288

Sandset EC, Murray GD, Bath PM, Kjeldsen SE, Berge E, Scandinavian Candesartan Acute Stroke Trial (SCAST) Study Group (2012)
Relation between change in blood pressure in acute stroke and risk of early adverse events and poor outcome
Stroke, 43 (8), 2108-14
DOI 10.1161/STROKEAHA.111.647362, PubMed 22627991

Schmieder RE, Redon J, Grassi G, Kjeldsen SE, Mancia G, Narkiewicz K, Parati G, Ruilope L, van de Borne P, Tsioufis C (2012)
ESH position paper: renal denervation - an interventional therapy of resistant hypertension
J Hypertens, 30 (5), 837-41
DOI 10.1097/HJH.0b013e328352ce78, PubMed 22469838

Schwartz GG, Olsson AG, Abt M, Ballantyne CM, Barter PJ, Brumm J, Chaitman BR, Holme IM, Kallend D, Leiter LA, Leitersdorf E, McMurray JJ, Mundl H, Nicholls SJ, Shah PK, Tardif JC, Wright RS, dal-OUTCOMES Investigators (2012)
Effects of dalcetrapib in patients with a recent acute coronary syndrome
N Engl J Med, 367 (22), 2089-99
DOI 10.1056/NEJMoa1206797, PubMed 23126252

Semb AG, Kvien TK, DeMicco DA, Fayyad R, Wun CC, LaRosa J, Betteridge J, Pedersen TR, Holme I (2012)
Prediction of cardiovascular events in patients with ankylosing spondylitis and psoriatic arthritis: role of lipoproteins in a high-risk population
J Rheumatol, 39 (7), 1433-40
DOI 10.3899/jrheum.111307, PubMed 22660802

Semb AG, Kvien TK, DeMicco DA, Fayyad R, Wun CC, LaRosa JC, Betteridge J, Pedersen TR, Holme I (2012)
Effect of intensive lipid-lowering therapy on cardiovascular outcome in patients with and those without inflammatory joint disease
Arthritis Rheum, 64 (9), 2836-46
DOI 10.1002/art.34524, PubMed 22576673

Sletten IN, Nordsletten L, Hjorthaug GA, Hellund JC, Holme I, Kvernmo HD (2012)
Assessment of volar angulation and shortening in 5th metacarpal neck fractures: an inter- and intra-observer validity and reliability study
J Hand Surg Eur Vol, 38 (6), 658-66
DOI 10.1177/1753193412461582, PubMed 23060463

Søraas CL, Friis C, Engebretsen KV, Sandvik L, Kjeldsen SE, Tønnessen T (2012)
Troponin T is a better predictor than creatine kinase-MB of long-term mortality after coronary artery bypass graft surgery
Am Heart J, 164 (5), 779-85
DOI 10.1016/j.ahj.2012.05.027, PubMed 23137510

Soveri I, Holme I, Holdaas H, Budde K, Jardine AG, Fellström B (2012)
A cardiovascular risk calculator for renal transplant recipients
Transplantation, 94 (1), 57-62
DOI 10.1097/TP.0b013e3182516cdc, PubMed 22683851

Telle-Hansen VH, Narverud I, Retterstøl K, Wesseltoft-Rao N, Mosdøl A, Granlund L, Christiansen KF, Lamglait A, Halvorsen B, Holven KB, Ulven SM (2012)
Substitution of TAG oil with diacylglycerol oil in food items improves the predicted 10 years cardiovascular risk score in healthy, overweight subjects
J Nutr Sci, 1, e17
DOI 10.1017/jns.2012.18, PubMed 25191546

Tonstad S, Aubin HJ (2012)
Efficacy of a dose range of surinabant, a cannabinoid receptor blocker, for smoking cessation: a randomized controlled clinical trial
J Psychopharmacol, 26 (7), 1003-9
DOI 10.1177/0269881111431623, PubMed 22219220

Vollrath ME, Stene-Larsen K, Tonstad S, Rothbart MK, Hampson SE (2012)
Associations between temperament at age 1.5 years and obesogenic diet at ages 3 and 7 years
J Dev Behav Pediatr, 33 (9), 721-7
DOI 10.1097/DBP.0b013e31826bac0d, PubMed 23117597

Waters DD, Ho JE, Boekholdt SM, DeMicco DA, Kastelein JJ, Messig M, Breazna A, Pedersen TR (2012)
Cardiovascular event reduction versus new-onset diabetes during atorvastatin therapy: effect of baseline risk factors for diabetes
J Am Coll Cardiol, 61 (2), 148-52
DOI 10.1016/j.jacc.2012.09.042, PubMed 23219296

Weber MA, Julius S, Kjeldsen SE, Jia Y, Brunner HR, Zappe DH, Hua TA, McInnes GT, Schork A, Mancia G, Zanchetti A (2012)
Cardiovascular outcomes in hypertensive patients: comparing single-agent therapy with combination therapy
J Hypertens, 30 (11), 2213-22
DOI 10.1097/HJH.0b013e3283582ed6, PubMed 23011525

Publications Division of Medicine

Publications (original articles or review articles) published in 2012 from OUS - Section of Preventive Medicine

42 publications found

Aksnes TA, Skårn SN, Kjeldsen SE (2012)
Treatment of hypertension in diabetes: what is the best therapeutic option?
Expert Rev Cardiovasc Ther, 10 (6), 727-34
DOI 10.1586/erc.12.59, PubMed 22894629

Boekholdt SM, Arsenault BJ, Mora S, Pedersen TR, LaRosa JC, Nestel PJ, Simes RJ, Durrington P, Hitman GA, Welch KM, DeMicco DA, Zwinderman AH, Clearfield MB, Downs JR, Tonkin AM, Colhoun HM, Gotto AM, Ridker PM, Kastelein JJ (2012)
Association of LDL cholesterol, non-HDL cholesterol, and apolipoprotein B levels with risk of cardiovascular events among patients treated with statins: a meta-analysis
JAMA, 307 (12), 1302-9
DOI 10.1001/jama.2012.366, PubMed 22453571

Cameron J, Bogsrud MP, Tveten K, Strøm TB, Holven K, Berge KE, Leren TP (2012)
Serum levels of proprotein convertase subtilisin/kexin type 9 in subjects with familial hypercholesterolemia indicate that proprotein convertase subtilisin/kexin type 9 is cleared from plasma by low-density lipoprotein receptor-independent pathways
Transl Res, 160 (2), 125-30
DOI 10.1016/j.trsl.2012.01.010, PubMed 22683370

Farnier M, Marcereuil D, De Niet S, Ducobu J, Steinmetz A, Retterstøl K, Bryniarski L, Császár A, Vanderbist F (2012)
Safety of a fixed-dose combination of fenofibrate/pravastatin 160 mg/40 mg in patients with mixed hyperlipidaemia: a pooled analysis from a database of clinical trials
Clin Drug Investig, 32 (4), 281-91
DOI 10.2165/11630820-000000000-00000, PubMed 22350498

Farnier M, Retterstøl K, Steinmetz A, Császár A (2012)
Comparative efficacy and safety of fenofibrate/pravastatin plus ezetimibe triple therapy and simvastatin/ezetimibe dual therapy in type 2 diabetic patients with mixed hyperlipidaemia and cardiovascular disease
Diab Vasc Dis Res, 9 (3), 205-15
DOI 10.1177/1479164111430715, PubMed 22228773

Fretheim A, Odgaard-Jensen J, Brørs O, Madsen S, Njølstad I, Norheim OF, Svilaas A, Kristiansen IS, Thürmer H, Flottorp S (2012)
Comparative effectiveness of antihypertensive medication for primary prevention of cardiovascular disease: systematic review and multiple treatments meta-analysis
BMC Med, 10, 33
DOI 10.1186/1741-7015-10-33, PubMed 22480336

Græsdal A, Bogsrud MP, Holven KB, Nenseter MS, Narverud I, Langslet G, Brekke M, Retterstøl K, Arnesen KE, Ose L (2012)
Apheresis in homozygous familial hypercholesterolemia: the results of a follow-up of all Norwegian patients with homozygous familial hypercholesterolemia
J Clin Lipidol, 6 (4), 331-9
DOI 10.1016/j.jacl.2012.03.004, PubMed 22836070

Grundvold I, Skretteberg PT, Liestøl K, Erikssen G, Kjeldsen SE, Arnesen H, Erikssen J, Bodegard J (2012)
Upper normal blood pressures predict incident atrial fibrillation in healthy middle-aged men: a 35-year follow-up study
Hypertension, 59 (2), 198-204
DOI 10.1161/HYPERTENSIONAHA.111.179713, PubMed 22252392

Grundvold I, Skretteberg PT, Liestøl K, Gjesdal K, Erikssen G, Kjeldsen SE, Arnesen H, Erikssen J, Bodegard J (2012)
Importance of physical fitness on predictive effect of body mass index and weight gain on incident atrial fibrillation in healthy middle-age men
Am J Cardiol, 110 (3), 425-32
DOI 10.1016/j.amjcard.2012.03.043, PubMed 22579085

Hamrefors V, Sjögren M, Almgren P, Wahlstrand B, Kjeldsen S, Hedner T, Melander O (2012)
Pharmacogenetic implications for eight common blood pressure-associated single-nucleotide polymorphisms
J Hypertens, 30 (6), 1151-60
DOI 10.1097/HJH.0b013e3283536338, PubMed 22525200

Hassellund SS, Flaa A, Kjeldsen SE, Seljeflot I, Karlsen A, Erlund I, Rostrup M (2012)
Effects of anthocyanins on cardiovascular risk factors and inflammation in pre-hypertensive men: a double-blind randomized placebo-controlled crossover study
J Hum Hypertens, 27 (2), 100-6
DOI 10.1038/jhh.2012.4, PubMed 22336903

Heggen E, Klemsdal TO, Haugen F, Holme I, Tonstad S (2012)
Effect of a low-fat versus a low-gycemic-load diet on inflammatory biomarker and adipokine concentrations
Metab Syndr Relat Disord, 10 (6), 437-42
DOI 10.1089/met.2012.0012, PubMed 22889406

Hodnesdal C, Prestgaard E, Erikssen G, Gjesdal K, Kjeldsen SE, Liestol K, Skretteberg PT, Erikssen J, Bodegard J (2012)
Rapidly upsloping ST-segment on exercise ECG: a marker of reduced coronary heart disease mortality risk
Eur J Prev Cardiol, 20 (4), 541-8
DOI 10.1177/2047487312444370, PubMed 22492865

Holme I, Fellström BC, Jardine AG, Hartmann A, Holdaas H (2012)
Model comparisons of competing risk and recurrent events for graft failure in renal transplant recipients
Clin J Am Soc Nephrol, 8 (2), 241-7
DOI 10.2215/CJN.03760412, PubMed 23160259

Karlsen A, Svendsen M, Seljeflot I, Laake P, Duttaroy AK, Drevon CA, Arnesen H, Tonstad S, Blomhoff R (2012)
Kiwifruit decreases blood pressure and whole-blood platelet aggregation in male smokers
J Hum Hypertens, 27 (2), 126-30
DOI 10.1038/jhh.2011.116, PubMed 22258209

Kjeldsen SE, Messerli FH, Chiang CE, Meredith PA, Liu L (2012)
Are fixed-dose combination antihypertensives suitable as first-line therapy?
Curr Med Res Opin, 28 (10), 1685-97
DOI 10.1185/03007995.2012.729505, PubMed 22978777

Larstorp AC, Ariansen I, Gjesdal K, Olsen MH, Ibsen H, Devereux RB, Okin PM, Dahlöf B, Kjeldsen SE, Wachtell K (2012)
Association of pulse pressure with new-onset atrial fibrillation in patients with hypertension and left ventricular hypertrophy: the Losartan Intervention For Endpoint (LIFE) reduction in hypertension study
Hypertension, 60 (2), 347-53
DOI 10.1161/HYPERTENSIONAHA.112.195032, PubMed 22753219

Larstorp AC, Okin PM, Devereux RB, Olsen MH, Ibsen H, Dahlöf B, Kjeldsen SE, Wachtell K (2012)
Regression of ECG-LVH is associated with lower risk of new-onset heart failure and mortality in patients with isolated systolic hypertension; The LIFE study
Am J Hypertens, 25 (10), 1101-9
DOI 10.1038/ajh.2012.86, PubMed 22717544

Manolis AJ, Rosei EA, Coca A, Cifkova R, Erdine SE, Kjeldsen S, Lip GY, Narkiewicz K, Parati G, Redon J, Schmieder R, Tsioufis C, Mancia G (2012)
Hypertension and atrial fibrillation: diagnostic approach, prevention and treatment. Position paper of the Working Group 'Hypertension Arrhythmias and Thrombosis' of the European Society of Hypertension
J Hypertens, 30 (2), 239-52
DOI 10.1097/HJH.0b013e32834f03bf, PubMed 22186358

Narverud I, Halvorsen B, Nenseter MS, Retterstøl K, Yndestad A, Dahl TB, Ulven SM, Olstad OK, Ose L, Holven KB, Aukrust P (2012)
Oxidized LDL level is related to gene expression of tumour necrosis factor super family members in children and young adults with familial hypercholesterolaemia
J Intern Med, 273 (1), 69-78
DOI 10.1111/j.1365-2796.2012.02584.x, PubMed 22891927

Narverud I, Iversen PO, Aukrust P, Halvorsen B, Ueland T, Johansen SG, Nenseter MS, Sandset PM, Ulven SM, Ose L, Retterstøl K, Holven KB (2012)
Maternal familial hypercholesterolaemia (FH) confers altered haemostatic profile in offspring with and without FH
Thromb Res, 131 (2), 178-82
DOI 10.1016/j.thromres.2012.11.008, PubMed 23199546

Nenseter MS, Narverud I, Græsdal A, Bogsrud MP, Aukrust P, Retterstøl K, Ose L, Halvorsen B, Holven KB (2012)
Cholesterol efflux mediators in homozygous familial hypercholesterolemia patients on low-density lipoprotein apheresis
J Clin Lipidol, 7 (2), 109-16
DOI 10.1016/j.jacl.2012.08.001, PubMed 23415429

Nenseter MS, Narverud I, Græsdal A, Bogsrud MP, Halvorsen B, Ose L, Aukrust P, Holven KB (2012)
Elevated serum MMP-9/TIMP-1 ratio in patients with homozygous familial hypercholesterolemia: effects of LDL-apheresis
Cytokine, 61 (1), 194-8
DOI 10.1016/j.cyto.2012.09.016, PubMed 23131422

Okin PM, Hille DA, Kjeldsen SE, Dahlöf B, Devereux RB (2012)
Impact of lower achieved blood pressure on outcomes in hypertensive patients
J Hypertens, 30 (4), 802-10; discussion 810
DOI 10.1097/HJH.0b013e3283516499, PubMed 22343536

Okin PM, Kjeldsen SE, Lindholm LH, Dahlöf B, Devereux RB (2012)
The relationship of electrocardiographic left ventricular hypertrophy to decreased serum potassium
Blood Press, 21 (3), 146-52
DOI 10.3109/08037051.2011.649537, PubMed 22243363

Perlini S, Naditch-Brule L, Farsang C, Zidek W, Kjeldsen SE (2012)
Pulse pressure and heart rate in patients with metabolic syndrome across Europe: insights from the GOOD survey
J Hum Hypertens, 27 (7), 412-6
DOI 10.1038/jhh.2012.61, PubMed 23235366

Preiss D, Tikkanen MJ, Welsh P, Ford I, Lovato LC, Elam MB, LaRosa JC, DeMicco DA, Colhoun HM, Goldenberg I, Murphy MJ, MacDonald TM, Pedersen TR, Keech AC, Ridker PM, Kjekshus J, Sattar N, McMurray JJ (2012)
Lipid-modifying therapies and risk of pancreatitis: a meta-analysis
JAMA, 308 (8), 804-11
DOI 10.1001/jama.2012.8439, PubMed 22910758

Rollefstad S, Kvien TK, Holme I, Eirheim AS, Pedersen TR, Semb AG (2012)
Treatment to lipid targets in patients with inflammatory joint diseases in a preventive cardio-rheuma clinic
Ann Rheum Dis, 72 (12), 1968-74
DOI 10.1136/annrheumdis-2012-202789, PubMed 23264359

Ruwald AC, Westergaard B, Sehestedt T, Kjeldsen SE, Lindholm LH, Wachtell K, Devereux RB, Ibsen H, Nieminen MS, Dahlöf B, Olsen MH (2012)
Losartan versus atenolol-based antihypertensive treatment reduces cardiovascular events especially well in elderly patients: the Losartan Intervention For Endpoint reduction in hypertension (LIFE) study
J Hypertens, 30 (6), 1252-9
DOI 10.1097/HJH.0b013e328352f7f6, PubMed 22499288

Sandset EC, Murray GD, Bath PM, Kjeldsen SE, Berge E, Scandinavian Candesartan Acute Stroke Trial (SCAST) Study Group (2012)
Relation between change in blood pressure in acute stroke and risk of early adverse events and poor outcome
Stroke, 43 (8), 2108-14
DOI 10.1161/STROKEAHA.111.647362, PubMed 22627991

Schmieder RE, Redon J, Grassi G, Kjeldsen SE, Mancia G, Narkiewicz K, Parati G, Ruilope L, van de Borne P, Tsioufis C (2012)
ESH position paper: renal denervation - an interventional therapy of resistant hypertension
J Hypertens, 30 (5), 837-41
DOI 10.1097/HJH.0b013e328352ce78, PubMed 22469838

Schwartz GG, Olsson AG, Abt M, Ballantyne CM, Barter PJ, Brumm J, Chaitman BR, Holme IM, Kallend D, Leiter LA, Leitersdorf E, McMurray JJ, Mundl H, Nicholls SJ, Shah PK, Tardif JC, Wright RS, dal-OUTCOMES Investigators (2012)
Effects of dalcetrapib in patients with a recent acute coronary syndrome
N Engl J Med, 367 (22), 2089-99
DOI 10.1056/NEJMoa1206797, PubMed 23126252

Semb AG, Kvien TK, DeMicco DA, Fayyad R, Wun CC, LaRosa J, Betteridge J, Pedersen TR, Holme I (2012)
Prediction of cardiovascular events in patients with ankylosing spondylitis and psoriatic arthritis: role of lipoproteins in a high-risk population
J Rheumatol, 39 (7), 1433-40
DOI 10.3899/jrheum.111307, PubMed 22660802

Semb AG, Kvien TK, DeMicco DA, Fayyad R, Wun CC, LaRosa JC, Betteridge J, Pedersen TR, Holme I (2012)
Effect of intensive lipid-lowering therapy on cardiovascular outcome in patients with and those without inflammatory joint disease
Arthritis Rheum, 64 (9), 2836-46
DOI 10.1002/art.34524, PubMed 22576673

Sletten IN, Nordsletten L, Hjorthaug GA, Hellund JC, Holme I, Kvernmo HD (2012)
Assessment of volar angulation and shortening in 5th metacarpal neck fractures: an inter- and intra-observer validity and reliability study
J Hand Surg Eur Vol, 38 (6), 658-66
DOI 10.1177/1753193412461582, PubMed 23060463

Søraas CL, Friis C, Engebretsen KV, Sandvik L, Kjeldsen SE, Tønnessen T (2012)
Troponin T is a better predictor than creatine kinase-MB of long-term mortality after coronary artery bypass graft surgery
Am Heart J, 164 (5), 779-85
DOI 10.1016/j.ahj.2012.05.027, PubMed 23137510

Soveri I, Holme I, Holdaas H, Budde K, Jardine AG, Fellström B (2012)
A cardiovascular risk calculator for renal transplant recipients
Transplantation, 94 (1), 57-62
DOI 10.1097/TP.0b013e3182516cdc, PubMed 22683851

Telle-Hansen VH, Narverud I, Retterstøl K, Wesseltoft-Rao N, Mosdøl A, Granlund L, Christiansen KF, Lamglait A, Halvorsen B, Holven KB, Ulven SM (2012)
Substitution of TAG oil with diacylglycerol oil in food items improves the predicted 10 years cardiovascular risk score in healthy, overweight subjects
J Nutr Sci, 1, e17
DOI 10.1017/jns.2012.18, PubMed 25191546

Tonstad S, Aubin HJ (2012)
Efficacy of a dose range of surinabant, a cannabinoid receptor blocker, for smoking cessation: a randomized controlled clinical trial
J Psychopharmacol, 26 (7), 1003-9
DOI 10.1177/0269881111431623, PubMed 22219220

Vollrath ME, Stene-Larsen K, Tonstad S, Rothbart MK, Hampson SE (2012)
Associations between temperament at age 1.5 years and obesogenic diet at ages 3 and 7 years
J Dev Behav Pediatr, 33 (9), 721-7
DOI 10.1097/DBP.0b013e31826bac0d, PubMed 23117597

Waters DD, Ho JE, Boekholdt SM, DeMicco DA, Kastelein JJ, Messig M, Breazna A, Pedersen TR (2012)
Cardiovascular event reduction versus new-onset diabetes during atorvastatin therapy: effect of baseline risk factors for diabetes
J Am Coll Cardiol, 61 (2), 148-52
DOI 10.1016/j.jacc.2012.09.042, PubMed 23219296

Weber MA, Julius S, Kjeldsen SE, Jia Y, Brunner HR, Zappe DH, Hua TA, McInnes GT, Schork A, Mancia G, Zanchetti A (2012)
Cardiovascular outcomes in hypertensive patients: comparing single-agent therapy with combination therapy
J Hypertens, 30 (11), 2213-22
DOI 10.1097/HJH.0b013e3283582ed6, PubMed 23011525